MID-VOLUME · SEX-BALANCED
cariprazine Side Effects
cariprazine (also sold as Vraylar) sits MID-VOLUME #334 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 67% of sex-coded reports are female (4,591 F / 2,240 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 8,574
- FAERS reports
FDA Adverse Event Reporting System extract for cariprazine. Stamp set WATCHLIST · DEATH-MARKED · HOSP-MID. How figures are compiled.
cariprazine reporting skew - 67% of sex-coded reports are female (4,591 F / 2,240 M). Volume band MID-VOLUME #334 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for cariprazine (Vraylar) (8,574 reports). Signature SEX-BALANCED. Dominant age band on file: 18-44. Educational reference only.
Counts from the openFDA FAERS extract (2011–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
WEIGHT INCREASED leads 441 of 8,574 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (1,655 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 225 reports (2.6% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 95 |
| COMPLETED SUICIDE | 70 |
| TOXICITY TO VARIOUS AGENTS | 13 |
| CARDIO-RESPIRATORY ARREST | 8 |
| FALL | 6 |
| CARDIAC ARREST | 5 |
| MYOCARDIAL INFARCTION | 5 |
| CEREBROVASCULAR ACCIDENT | 4 |
| PNEUMONIA ASPIRATION | 4 |
| AKATHISIA | 3 |
| FEELING ABNORMAL | 3 |
| HOSPITALISATION | 3 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 3 |
| NEOPLASM MALIGNANT | 3 |
| OVERDOSE | 3 |
| THERAPY CESSATION | 3 |
| ACCIDENTAL OVERDOSE | 2 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,156, 13.5%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| SUICIDAL IDEATION | 85 |
| DRUG INTERACTION | 83 |
| HOSPITALISATION | 70 |
| INSOMNIA | 56 |
| SUICIDE ATTEMPT | 56 |
| TREMOR | 56 |
| AKATHISIA | 55 |
| WEIGHT INCREASED | 55 |
| ANXIETY | 51 |
| FALL | 50 |
| FATIGUE | 49 |
| INTENTIONAL OVERDOSE | 49 |
| TREATMENT NONCOMPLIANCE | 48 |
| CONDITION AGGRAVATED | 47 |
| DEPRESSION | 47 |
| EXTRAPYRAMIDAL DISORDER | 46 |
| MANIA | 45 |
| NAUSEA | 43 |
How to read cariprazine FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)
FAERS holds 8,574 voluntary reports linked to cariprazine (Vraylar), 2011-2025. Death is listed on 225 (2.6%). Hospitalization appears on 1,156 (13.5%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-MARKED · HOSP-MID as signal-detection rates next to 67% of sex-coded reports are female (4,591 F / 2,240 M).
Read with cariprazine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 8,530 FAERS cases (Δ 44 lighter vs cariprazine); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 8,521 FAERS cases (Δ 53 lighter vs cariprazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 8,461 FAERS cases (Δ 113 lighter vs cariprazine); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 8,426 FAERS cases (Δ 148 lighter vs cariprazine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 59.5 pp vs cariprazine's DEATH-MARKED): CASELOAD · HOSP-MID.
cariprazine stamps WATCHLIST · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.